HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoping Wang Selected Research

HSP72 Heat-Shock Proteins

2/2013HSP72 and gp96 in gastroenterological cancers.
1/2010Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human esophageal squamous cell carcinoma.
12/2008Complex formation between heat shock protein 72 and hepatitis B virus X protein in hepatocellular carcinoma tissues.
7/2008Heat shock protein 72 associated with CD44v6 in human colonic adenocarcinoma.
1/2008Immunolocalisation of heat shock protein 72 and glycoprotein 96 in colonic adenocarcinoma.
4/2007Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoping Wang Research Topics

Disease

66Neoplasms (Cancer)
11/2022 - 03/2005
14Breast Neoplasms (Breast Cancer)
09/2021 - 09/2008
12Myocardial Infarction
01/2022 - 06/2013
12Lung Neoplasms (Lung Cancer)
02/2021 - 10/2003
9Neoplasm Metastasis (Metastasis)
11/2022 - 12/2008
9Heart Failure
02/2022 - 01/2016
9Schizophrenia (Dementia Praecox)
01/2021 - 01/2013
9Hepatocellular Carcinoma (Hepatoma)
01/2018 - 04/2007
8Infections
03/2022 - 08/2011
8Inflammation (Inflammations)
01/2022 - 02/2012
8Carcinoma (Carcinomatosis)
09/2020 - 10/2003
7Carcinogenesis
01/2022 - 06/2010
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 10/2005
7Adenocarcinoma of Lung
07/2012 - 10/2008
6Pain (Aches)
06/2022 - 01/2016
6Cardiotoxicity
01/2022 - 06/2019
6Inflammatory Breast Neoplasms
01/2021 - 11/2013
5Hemorrhage
01/2022 - 09/2019
5Reperfusion Injury
12/2021 - 01/2013
5Hypoxia (Hypoxemia)
01/2021 - 01/2012
5Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 07/2007
5Brain Ischemia (Cerebral Ischemia)
01/2019 - 01/2013
5Major Depressive Disorder (Major Depressive Disorders)
01/2018 - 03/2007
5Chronic Obstructive Pulmonary Disease (COPD)
03/2014 - 09/2006
4Wounds and Injuries (Trauma)
01/2022 - 11/2013
4Triple Negative Breast Neoplasms
01/2022 - 12/2015
4Fibrosis (Cirrhosis)
01/2022 - 11/2016
4Ischemia
01/2019 - 08/2015
4Adenocarcinoma
07/2008 - 10/2003
3Pathologic Complete Response
01/2022 - 01/2018
3Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2021
3Ischemic Stroke
11/2020 - 01/2015
3Liver Neoplasms (Liver Cancer)
01/2020 - 11/2016
3Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2018
3COVID-19
01/2020 - 01/2020
3Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 05/2012
3Pathologic Constriction (Stenosis)
01/2019 - 09/2014
3Mental Disorders (Mental Disorder)
01/2019 - 09/2011
3Sleep Initiation and Maintenance Disorders (Insomnia)
01/2018 - 09/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017 - 10/2003
3B-Cell Lymphoma (Lymphoma, B Cell)
11/2017 - 06/2013
3Colorectal Neoplasms (Colorectal Cancer)
02/2017 - 01/2013
3Alcoholism (Alcohol Abuse)
12/2016 - 08/2013
3Colitis
06/2016 - 09/2015
3Nevus (Nevi)
09/2015 - 12/2014
2Esophageal Squamous Cell Carcinoma
07/2022 - 01/2010
2Coronary Disease (Coronary Heart Disease)
02/2022 - 02/2021
2Rupture
01/2022 - 11/2009

Drug/Important Bio-Agent (IBA)

19Pharmaceutical PreparationsIBA
03/2021 - 09/2006
18Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2008
10Biological ProductsIBA
01/2022 - 11/2013
8FlavonoidsIBA
03/2021 - 06/2011
7Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2015
6CaspasesIBA
01/2022 - 02/2010
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 06/2019
6MicroRNAs (MicroRNA)IBA
02/2021 - 07/2010
6HSP72 Heat-Shock ProteinsIBA
02/2013 - 04/2007
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2011
5AntioxidantsIBA
03/2021 - 06/2011
5Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2019 - 03/2008
5Messenger RNA (mRNA)IBA
10/2018 - 10/2005
4LigandsIBA
11/2022 - 03/2013
4Peptides (Polypeptides)IBA
06/2022 - 08/2011
4danqi tongmaiIBA
02/2022 - 01/2020
4Long Noncoding RNAIBA
01/2022 - 01/2018
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2016
4Dacarbazine (DIC)FDA LinkGeneric
03/2021 - 06/2019
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 03/2013
4VaccinesIBA
11/2018 - 02/2013
4RNA (Ribonucleic Acid)IBA
01/2018 - 06/2015
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2018 - 04/2007
4ResveratrolIBA
08/2015 - 08/2011
4Bronchodilator Agents (Bronchodilators)IBA
10/2010 - 09/2006
3LipidsIBA
03/2022 - 11/2019
3Therapeutic UsesIBA
01/2022 - 10/2010
3Phosphotransferases (Kinase)IBA
01/2022 - 11/2013
3tyloxapolFDA Link
01/2022 - 01/2021
3Cadherins (E-Cadherin)IBA
12/2021 - 01/2021
3AcidsIBA
03/2021 - 11/2008
3Cholinergic ReceptorsIBA
01/2021 - 11/2016
3Transcription Factors (Transcription Factor)IBA
11/2020 - 01/2006
3Paclitaxel (Taxol)FDA LinkGeneric
09/2020 - 02/2010
3CytokinesIBA
09/2020 - 06/2011
3Antipsychotic Agents (Antipsychotics)IBA
01/2019 - 08/2014
3Caspase 3 (Caspase-3)IBA
11/2017 - 01/2011
3Antineoplastic Agents (Antineoplastics)IBA
02/2017 - 07/2014
3DobutamineFDA LinkGeneric
11/2016 - 06/2013
3artemisinin (artemisinine)IBA
10/2016 - 10/2013
3Dextran SulfateIBA
06/2016 - 09/2015
3Glycoproteins (Glycoprotein)IBA
02/2013 - 01/2008
3PolyphenolsIBA
07/2012 - 08/2011
3Molecular Chaperones (Chaperone, Molecular)IBA
12/2008 - 04/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006 - 11/2004
2Insulin (Novolin)FDA Link
06/2022 - 03/2013

Therapy/Procedure

27Therapeutics
01/2022 - 10/2003
11Drug Therapy (Chemotherapy)
07/2022 - 10/2003
8Immunotherapy
07/2022 - 04/2007
4Lasers (Laser)
02/2014 - 04/2007
3Neoadjuvant Therapy
07/2022 - 01/2018
3Radiofrequency Ablation
06/2021 - 03/2011